Defining populations at risk of rheumatoid arthritis: the first steps to prevention
Crossref DOI link: https://doi.org/10.1038/nrrheum.2014.82
Published Online: 2014-06-17
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hunt, Laura
Emery, Paul
Text and Data Mining valid from 2014-06-17
Article History
First Online: 17 June 2014
Competing interests
: P.E. has acted as a consultant for Abbott, BMS, Chugai, MSD, Pfizer, Novartis, Roche and UCB. L.H. declares no competing interests.